Peristomal Dermatology

ABSTRACT

Inflammatory or infectious conditions affecting the skin around an intestinal stoma are common and may be a source of considerable aggravation to patients. Recognition and prompt appropriate treatment of these conditions improves their quality of life. Peristomal pyoderma gangrenosum represents a most unusual peristomal skin condition that is difficult to treat; resolution often requires diagnosis and therapy of underlying inflammatory bowel disease.

KEYWORDS

Intestinal stomas - dermatology - pyoderma gangrenosum

REFERENCES

• 1 Colwell J, Goldberg M, Carmel J. The state of the standard diversion.  J Wound Ostomy Continence Nurs. 2001;  28 6-17
• 2 Erwin-Toth P. Prevention and management of peristomal skin complications.  Adv Skin Wound Care. 2001;  14 1-6
• 3 Collins F, Hampton S, White R. A-Z Dictionary of Wound Care. London; Quay Books 2002
• 4 Lyon C C, Smith A J, Griffiths C EM, Beck M H. The spectrum of skin disorders in abdominal stoma patients.  Br J Dermatol. 2000;  143(6) 1248-1260
• 5 Hampton B. Peristomal and stomal complications. In: Hampton B, Bryant R Ostomies and Continent Diversions: Nursing Management. St Louis, MO; Mosby 1992: 108
• 6 Evans E C, Gray M. What interventions are effective for the prevention and treatment of cutaneous candidiasis?.  J Wound Ostomy Continence Nurs. 2003;  30(1) 11-16
• 7 Ratliff C R, Donavan A M. Frequency of peristomal complications.  Ostomy Wound Manage. 2001;  47 26-29
• 8 Crawford F, Hart R, Bell-Syer S, Torgerson D, Young P, Russell I. Topical treatments for fungal infections of the skin and nails of the foot.  Cochrane Database System Review. 2002;  (2) CD001434
• 9 Brusting L A, Goeckerman W H, O'Leary P A. Pyoderma gangrenosum:Clinical and experimental observations in 5 cases occurring in adults.  Arch Dermatol. 1930;  22 655-680
• 10 Crowson A N, Mihm M C, Magro C. Pyoderma gangrenosum: a review.  J Cutaneous Pathol 2003. 30 97-107
• 11 Colwell J C. Stomal and peristomal complications. In: Colwell JC, Goldberg MT, Carmel JE Fecal and Urinary Diversions: Management Principles. St Louis, MO; Mosby 2004: 308-325
• 12 Faulds D, Goa K L, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.  Drugs. 1993;  45 953-1040
• 13 Loehner D, Casey K, Schoetz Jr D J. Peristomal dermatology.  Clin Colon Rectal Surg. 2002;  15 209-214